CoreCap Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Sell |
218
-19
| -8% | -$9.98K | ﹤0.01% | 936 |
|
|
2025
Q1 | $150K | Sell |
237
-29
| -11% | -$18.4K | 0.01% | 759 |
|
|
2024
Q4 | $189K | Sell |
266
-2,663
| -91% | -$1.9M | 0.01% | 722 |
|
|
2024
Q3 | $3.08M | Buy |
2,929
+2,616
| +836% | +$2.75M | 0.14% | 148 |
|
|
2024
Q2 | $329K | Sell |
313
-77
| -20% | -$80.9K | 0.03% | 291 |
|
|
2024
Q1 | $375K | Sell |
390
-1,274
| -77% | -$1.23M | 0.02% | 451 |
|
|
2023
Q4 | $1.46M | Buy |
1,664
+1,412
| +560% | +$1.24M | 0.09% | 202 |
|
|
2023
Q3 | $207K | Sell |
252
-30
| -11% | -$24.7K | 0.01% | 500 |
|
|
2023
Q2 | $203K | Buy |
+282
| New | +$203K | 0.01% | 533 |
|
|
2022
Q4 | $421K | Buy |
583
+212
| +57% | +$153K | 0.03% | 385 |
|
|
2022
Q3 | $256K | Sell |
371
-2,209
| -86% | -$1.52M | 0.02% | 441 |
|
|
2022
Q2 | $1.53M | Buy |
+2,580
| New | +$1.53M | 0.12% | 136 |
|
|
2022
Q1 | – | Sell |
-229
| Closed | -$145K | – | 1723 |
|
|
2021
Q4 | $145K | Buy |
+229
| New | +$145K | 0.01% | 624 |
|